Pravin Tp Kaumaya

6PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 25, 2025
Constructing the cure: engineering the next wave of antibody and cellular immune therapies.

Stefanie R Bailey, Eric Bartee, Kyle G Daniels

|May 06, 2025
Novel Chimeric CTLA-4 B-cell Epitope Peptide Vaccines Demonstrate Effective Antitumor Immunity with/without PD1/PDL1 Blockade in Multiple Syngeneic Murine Models of Breast and Colorectal Cancers.

Linlin Guo, Jay Overholser, Sarah Naylon

|Oct 10, 2022
A newly discovered PD-L1 B-cell epitope peptide vaccine (PDL1-Vaxx) exhibits potent immune responses and effective anti-tumor immunity in multiple syngeneic mice models and (synergizes) in combination with a dual HER-2 B-cell vaccine (B-Vaxx).

Linlin Guo, Jay Overholser, Heather Darby

|Mar 27, 2021
First prototype checkpoint inhibitor B-cell epitope vaccine (PD1-Vaxx) en route to human Phase 1 clinical trial in Australia and USA: exploiting future novel synergistic vaccine combinations.

Linlin Guo, Pravin T P Kaumaya

|Oct 29, 2020
Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.

Pravin T P Kaumaya, Linlin Guo, Jay Overholser

|Jun 23, 2020
B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine.

Pravin Tp Kaumaya

Pageof 1

Frequent Collaborators

1 joint publications

Eric Bartee

1 joint publications

Gregory B Lesinski

1 joint publications

Megen C Wittling

1 joint publications

Avery D Posey